Identification of risk factors for acute surgical site infections in musculoskeletal tumor patients using CDC/NHSN criteria

Bulletin of the Hospital for Joint Diseases

Volumn 73, Issue 4, 2015, Pages 233-238

  Lerman, Daniel M ^a   Blank, Alan T ^b   Billig, Jessica I ^b   Karia, Raj ^b   Rapp, Timothy B ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CLINDAMYCIN;

ADULT; AMPUTATION; ARTICLE; ENTEROBACTER CLOACAE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MUSCULOSKELETAL TUMOR; NONHUMAN; OPERATION DURATION; RACE; RETROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS PYOGENES; SURGICAL INFECTION; ACUTE DISEASE; ANCESTRY GROUP; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; ETHNOLOGY; MEDICAL RECORD; MICROBIOLOGY; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL DISEASES; NEOPLASMS; NEW YORK; ODDS RATIO; PATHOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; STATISTICAL MODEL; SURGICAL WOUND INFECTION;

ACUTE DISEASE; ADULT; CHI-SQUARE DISTRIBUTION; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL DISEASES; NEOPLASMS; NEW YORK CITY; ODDS RATIO; OPERATIVE TIME; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 84949970391     PISSN: 23284633     EISSN: 23285273     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002 Apr;23(4):183-9.
2. Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012 Sep;27(8 Suppl):61-5 e1.
3. Jeys LM, Grimer RJ, Carter SR, Tillman RM. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am. 2005 Apr;87(4):842-9.
4. Morris CD, Sepkowitz K, Healey J, et al. Prospective identification of risk factors for wound infection after lower extremity oncologic surgery. Ann Surg Oncol. 2003 Aug;10(7):778-82.
5. Morii T, Mochizuki K, Tajima T, et al. Surgical site infection in malignant soft tissue tumors. J Orthop Sci. 2012 Jan;17(1):51-7.
6. Li X, Moretti VM, Ashana AO, Lackman RD. Perioperative infection rate in patients with osteosarcomas treated with resection and prosthetic reconstruction. Clin Orthop Relat Res. 2011 Oct;469(10):2889-94.
7. Hardes J, Gebert C, Gosheger G, et al. Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg. 2006 Jul;126(5):289-96.
8. Gradl G, de Witte PG, Evans BT, et al. Surgical site infection in orthopaedic oncology. J Bone Joint Surg Am. 2014 Feb 5;96(3): 223-30.
9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309-32.
10. James PT. Obesity: the worldwide epidemic. Clin Dermatol. 2004 Jul-Aug;22(4):276-80.
11. Menke H, Klein A, John KD, Junginger T. Predictive value of ASA classification for the assessment of the perioperative risk. Int Surg. 1993 Jul-Sep;78(3):266-70.
12. Ortega G, Rhee DS, Abdullah F, et al. An evaluation of surgical site infections by wound classification system using the ACS-NSQIP. J Surg Res. 2012 May 1;174(1):33-8.
13. Torbert JT, Fox EJ, Hosalkar HS, et al. Endoprosthetic reconstructions: results of long-term followup of 139 patients. Clin Orthop Relat Res. 2005 Sep;438:51-9.
14. Hadden JW. Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol. 2003 Aug;3(8):1061-71.
15. Grimer RJ, Belthur M, Chandrasekar C, et al. Two-stage revision for infected endoprostheses used in tumor surgery. Clin Orthop Relat Res. 2002 Feb;(395):193-203.
16. Saddegh MK, Bauer HC. Wound complication in surgery of soft tissue sarcoma. Analysis of 103 consecutive patients managed without adjuvant therapy. Clin Orthop Relat Res. 1993 Apr:(289)247-53.
17. Kurtz SM, Ong KL, Lau E, et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010 Jan;468(1):52-6.
18. Nwachukwu BU, Kenny AD, Losina E, et al. Complications for racial and ethnic minority groups after total hip and knee replacement: a review of the literature. J Bone Joint Surg Am. 2010 Feb;92(2):338-45.
19. Blank AT, Takemoto RC, Patel NM, Rapp T. Sarcoma care in an urban healthcare system: which factors lead to variance of care. J Racial Ethn Health Disparities. Epub ahead of print 2014.
20. Jeys LM, Grimer RJ, Carter SR, et al. Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007 Oct;14(10):2887-95.
21. Cannon CP, Ballo MT, Pisters PW, et al. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer. 2006 Nov 15;107(10):2455-61.
22. O’Sullivan B, Davis AM, Zee B, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002 Jun 29;359(9325):2235-41.
23. Davis AM, Wood AM, Keenan AC, et al. Does body mass index affect clinical outcome post-operatively and at five years after primary unilateral total hip replacement performed for osteoarthritis? A multivariate analysis of prospective data. J Bone Joint Surg Br. 2011 Sep;93(9):1178-82.
24. Suleiman LI, Ortega G, Fullum TM, et al. Does BMI affect perioperative complications following total knee and hip arthroplasty? J Surg Res. 2012 May 1;174(1):7-11.